Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (331-340 of 489) with videos related to

Pageof 49
Sort By:
Neurology|August 3, 2019
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisSuzanne E Schindler, James G Bollinger, Vitaliy Ovod, et al.
Neurobiology of Aging|March 25, 2021
Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25Omar H Butt, Justin M Long, Rachel L Henson, et al.
Science Translational Medicine|January 11, 2019
Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's diseaseBrendan P Lucey, Austin McCullough, Eric C Landsness, et al.
Archives of Neurology|December 17, 2009
Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case reportNigel J Cairns, Milos D Ikonomovic, Tammie Benzinger, et al.
Neurology|September 11, 2020
Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trialYvette I Sheline, B Joy Snider, Joanne C Beer, et al.
Journal of Alzheimer'S Disease : JAD|November 8, 2018
Depression and Alzheimer's Disease Biomarkers Predict Driving DeclineGanesh M Babulal, Suzie Chen, Monique M Williams, et al.
Brain Research|March 21, 2020
Characterization of tissue and functional deficits in a clinically translational pig model of acute ischemic strokeErin E Kaiser, Elizabeth S Waters, Madison M Fagan, et al.
Brain : a Journal of Neurology|July 22, 2022
Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomesJustin M Long, Dean W Coble, Chengjie Xiong, et al.
Brain : a Journal of Neurology|June 12, 2016
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imagingBrian A Gordon, Karl Friedrichsen, Matthew Brier, et al.
Neurology|September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PETSuzanne E Schindler, Yan Li, Virginia D Buckles, et al.
Pageof 49

Showing results (331-340 of 489) with videos related to

Sort By:
Pageof 49
Neurology|August 3, 2019
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisSuzanne E Schindler, James G Bollinger, Vitaliy Ovod, et al.
Neurobiology of Aging|March 25, 2021
Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25Omar H Butt, Justin M Long, Rachel L Henson, et al.
Science Translational Medicine|January 11, 2019
Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's diseaseBrendan P Lucey, Austin McCullough, Eric C Landsness, et al.
Archives of Neurology|December 17, 2009
Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case reportNigel J Cairns, Milos D Ikonomovic, Tammie Benzinger, et al.
Neurology|September 11, 2020
Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trialYvette I Sheline, B Joy Snider, Joanne C Beer, et al.
Journal of Alzheimer'S Disease : JAD|November 8, 2018
Depression and Alzheimer's Disease Biomarkers Predict Driving DeclineGanesh M Babulal, Suzie Chen, Monique M Williams, et al.
Brain Research|March 21, 2020
Characterization of tissue and functional deficits in a clinically translational pig model of acute ischemic strokeErin E Kaiser, Elizabeth S Waters, Madison M Fagan, et al.
Brain : a Journal of Neurology|July 22, 2022
Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomesJustin M Long, Dean W Coble, Chengjie Xiong, et al.
Brain : a Journal of Neurology|June 12, 2016
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imagingBrian A Gordon, Karl Friedrichsen, Matthew Brier, et al.
Neurology|September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PETSuzanne E Schindler, Yan Li, Virginia D Buckles, et al.
Pageof 49